002219.SZ
002219.SZ
CNE1000009R5
NEW JOURNEY
Loading chart...

Company Profile

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as oncology, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Astragalus and Schisandra tablets, Maiping tablets, Qianlie Antong tablets, Prosta Antong tablets, Gongliuning capsules, cough and phlegm granules, cold and flu granules, Wuhu San, Wei Funing capsules, and other proprietary Chinese medicine products. In addition, it engages in cultivation of Chinese herbal medicine; investment management; retail business; wholesale trading activities; and provision of resident services. The company was formerly known as Hengkang Medical Group Co.,Ltd. New Journey Health Technology Group Co.,LTD was founded in 2001 and is headquartered in Beijing, China.

Related stocks

600682.SS
600682.SS • China
NANJING XINJIEKOU DEPT STORE
5.86 CNY
1.18B USD 1Y -19.5%
000516.SZ
000516.SZ • China
IMIC
4.48 CNY
1.5B USD 1Y -7.2%
6078.HK
6078.HK • China
HYGEIA HEALTH
9.61 HKD
737.5M USD 1Y -31.7%
301267.SZ
301267.SZ • China
Huaxia Eye
15.16 CNY
1.91B USD 1Y -24.3%
2273.HK
2273.HK • China
GUSHENGTANG
26.74 HKD
720.44M USD 1Y -15.9%
301239.SZ
301239.SZ • China
PRYK
31.33 CNY
701.42M USD 1Y -14.7%
600763.SS
600763.SS • China
TOPCHOICE MEDICAL CORPORATION
33.8 CNY
2.25B USD 1Y -24.3%
PARKHOSPS.NS
PARKHOSPS.NS • India
PARK MEDI WORLD LIMITED
270.8 INR
1.21B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
45.5% p.a.
Max Drawdown (5Y)
-70.3%
Sharpe Ratio (5Y)
-0.29
Beta Factor
0.26
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 211.0 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (45.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.5% in the extended horizon.
ende